P21(Waf1/Cip1) Protects Against P53-mediated Apoptosis of Human Melanoma Cells
Overview
Affiliations
The tumor suppressive effect of p53 is believed to be rooted in its two primary functions: the implementation of cellular growth arrest and the execution of apoptotic cell death. While p53-regulated expression of the cyclin-dependent kinase inhibitor p21(Waf1/Cip1) appears to be central for the implementation of G1 arrest, the participation of p21(Waf1/Cip1) in p53-triggered cell death remains controversial. In the present study, overexpression of p53 in human melanoma SK-MEL-110 cells through use of an adenoviral expression vector (AdCMV.p53) was found to result in apoptosis, while similar infection of primary vascular smooth muscle cells (VSMC) instead resulted in a moderate inhibition of growth. Expression of p21(Waf1/Cip1) was strongly elevated in VSMC, but showed little change in SK-MEL-110 cells, although expression of another p53-regulated gene (GADD45) was comparable in both AdCMV.p53-infected cell types. Evidence that p21(Waf1/Cip1) expression may be required for surviving p53-induced cell death was further supported by the finding that p53 overexpression was highly toxic for p21-deficient mouse embryonal fibroblasts (p21-/- MEFs). In both SK-MEL-110 and p21-/- MEFs, adenovirus-driven ectopic expression of p21(Waf1/Cip1) resulted in a substantial protection against p53-induced apoptosis, indicating that p21(Waf1/Cip1) rescued cells from a path of programmed cell death to one of enhanced survival.
Hashimoto Y, Tokumoto Y, Watanabe T, Ogi Y, Sugishita H, Akita S Sci Rep. 2024; 14(1):9029.
PMID: 38641657 PMC: 11031597. DOI: 10.1038/s41598-024-59671-7.
Wen D, Liu W, Lu Z, Cao Y, Ji Q, Wei W Front Oncol. 2021; 11:647034.
PMID: 34017682 PMC: 8129558. DOI: 10.3389/fonc.2021.647034.
Lamb D, Rust A, Rudisch A, Gluxam T, Harrer N, Machat H Oncotarget. 2020; 11(14):1257-1272.
PMID: 32292575 PMC: 7147091. DOI: 10.18632/oncotarget.27545.
Human mesenchymal stem cells are resistant to UV-B irradiation.
Lopez Perez R, Brauer J, Ruhle A, Trinh T, Sisombath S, Wuchter P Sci Rep. 2019; 9(1):20000.
PMID: 31882818 PMC: 6934474. DOI: 10.1038/s41598-019-56591-9.
Shamloo B, Usluer S Cancers (Basel). 2019; 11(8).
PMID: 31416295 PMC: 6721478. DOI: 10.3390/cancers11081178.